Related Experiment Video

Updated: Jun 12, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

[Effects of decreased leptin expression on liver fibrosis]

Hai-juan Feng1, Jing Zhu, Liang Pan

  • 1Department of Gastroenterology, the Affiliated Hospital of Nantong University, Nantong Jiangsu Province 226000, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|June 1, 2010
PubMed
Abstract

Insights

Decreased leptin expression in rats significantly reduced liver fibrosis and collagen deposition. This finding suggests leptin plays a key role in the development of liver fibrosis.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Genetics

Context:

  • Liver fibrosis is a significant health concern with limited treatment options.
  • Leptin, a hormone involved in metabolism, has been implicated in fibrotic processes.
  • Understanding leptin's role could reveal new therapeutic targets for liver disease.

Purpose:

  • To investigate the impact of reducing leptin expression on liver fibrosis.
  • To determine if leptin downregulation can ameliorate established liver fibrosis.

Summary:

  • Small interfering RNA targeting the leptin gene was used to decrease leptin expression in a rat model of carbon tetrachloride-induced liver fibrosis.
  • Leptin messenger RNA and protein levels were significantly reduced in treated rats.
  • Deposition of type I and type III collagen, key markers of fibrosis, was also significantly decreased.

Impact:

  • This study demonstrates that inhibiting leptin expression can prevent the progression of liver fibrosis.
  • Targeting leptin represents a potential therapeutic strategy for managing liver fibrosis and related conditions.

More Related Videos

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...